GE HealthCare Technologies (GEHC)

The headline here is beat-and-raise with PCS finally turning positive, but the sleeper story is that orders growth cratered to 4% from 11.1% and book-to-bill fell to 1.03x, while the one unit-economics metric investors actually track on Fercato, customer conversion rate, quietly lost its number this quarter. The binding constraint isn't demand, it's disclosure: management is asking the market to take 'about the same percentage' and 'strong as it's ever been' on faith exactly when the hard numbers (orders, book-to-bill) are softening. Pete Arduini's own words about deals sliding by a week creating lumpiness is the tell, that's a defense, not an explanation backed by data. Add a PCS CEO departure mid-strategic-review and a brand-new CFO still finding his footing, and this is a quarter to trust the beat but question the trend. My view changes if Q4 book-to-bill snaps back above 1.0x with a disclosed Fercato conversion percentage, that would confirm this quarter's softness was genuinely timing, not the first crack in demand.